An Adenovirus Vector Incorporating Carbohydrate Binding Domains Utilizes Glycans for Gene Transfer

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Kim, Julius W ^a   Glasgow, Joel N ^d   Nakayama, Masaharu ^c   Ak, Ferhat ^b   Ugai, Hideyo ^a   Curiel, David T ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c KYUSHU UNIVERSITY   (Japan)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GLYCAN;

ADENOVIRUS; ARTICLE; CARBOHYDRATE ANALYSIS; CELL SURFACE; CONTROLLED STUDY; DNA MODIFICATION; DOWN REGULATION; EMBRYO; FEMALE; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; GLYCATION; HUMAN; HUMAN CELL; MALE; THERMOSTABILITY; VIRAL GENE DELIVERY SYSTEM; VIRAL TROPISM; VIRUS PARTICLE; VIRUS REPLICATION;

ADENOVIRUSES, HUMAN; ADENOVIRUSES, PORCINE; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; DNA PRIMERS; GENE TARGETING; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HUMANS; NEOPLASMS; PLASMIDS; POLYSACCHARIDES;

EID: 84873246408     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055533     Document Type: Article

References (76)

1. Short JJ, Curiel DT, (2009) Oncolytic adenoviruses targeted to cancer stem cells. Mol Cancer Ther 8: 2096-2102.
2. Glasgow JN, Everts M, Curiel DT, (2006) Transductional targeting of adenovirus vectors for gene therapy. Cancer Gene Ther 13: 830-844.
3. Journal of Gene Medicine website. Gene Therapy Clinical Trials Worldwide Database (2012). Available: http://www.wiley.com//legacy/wileychi/genmed/clinical/ Accessed Jan. 3, 2013.
4. Tomko RP, Xu R, Philipson L, (1997) HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A 94: 3352-3356.
5. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, et al. (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275: 1320-1323.
6. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR, (1993) Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73: 309-319.
7. Li E, Brown SL, Stupack DG, Puente XS, Cheresh DA, et al. (2001) Integrin alpha(v)beta1 is an adenovirus coreceptor. J Virol 75: 5405-5409.
8. Davison E, Diaz RM, Hart IR, Santis G, Marshall JF, (1997) Integrin alpha5beta1-mediated adenovirus infection is enhanced by the integrin-activating antibody TS2/16. J Virol 71: 6204-6207.
9. Okegawa T, Pong RC, Li Y, Bergelson JM, Sagalowsky AI, et al. (2001) The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure. Cancer Res 61: 6592-6600.
10. Kanerva A, Hemminki A, (2005) Adenoviruses for treatment of cancer. Ann Med 37: 33-43.
11. Kasono K, Blackwell JL, Douglas JT, Dmitriev I, Strong TV, et al. (1999) Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector. Clin Cancer Res 5: 2571-2579.
12. Miller CR, Buchsbaum DJ, Reynolds PN, Douglas JT, Gillespie GY, et al. (1998) Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res 58: 5738-5748.
13. Okegawa T, Li Y, Pong RC, Bergelson JM, Zhou J, et al. (2000) The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. Cancer Res 60: 5031-5036.
14. Hakomori S, (1996) Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 56: 5309-5318.
15. Cazet A, Julien S, Bobowski M, Burchell J, Delannoy P, (2010) Tumour-associated carbohydrate antigens in breast cancer. Breast Cancer Res 12: 204.
16. Dempsey E, Rudd PM, (2012) Acute phase glycoproteins: bystanders or participants in carcinogenesis? Ann N Y Acad Sci 1253: 122-132.
17. Drake PM, Cho W, Li B, Prakobphol A, Johansen E, et al. (2010) Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin Chem 56: 223-236.
18. Reis CA, Osorio H, Silva L, Gomes C, David L, (2010) Alterations in glycosylation as biomarkers for cancer detection. J Clin Pathol 63: 322-329.
19. Kleiboeker SB, (1995) Sequence analysis of the fiber genomic region of a porcine adenovirus predicts a novel fiber protein. Virus Res 39: 299-309.
20. Guardado-Calvo P, Llamas-Saiz AL, Fox GC, Glasgow JN, van Raaij MJ, (2009) Crystallization of the head and galectin-like domains of porcine adenovirus isolate NADC-1 fibre. Acta Crystallogr Sect F Struct Biol Cryst Commun 65: 1149-1152.
21. Guardado-Calvo P, Munoz EM, Llamas-Saiz AL, Fox GC, Kahn R, et al. (2010) Crystallographic Structure of Porcine Adenovirus Type 4 Fiber Head and Galectin Domains. Journal of Virology 84: 10558-10568.
22. Battacharya M, Barlow JJ, (1968) Tumor specific antigens associated with human ovarian cystadenocarcinoma. Handbook of Cancer Immunology 4: 277-295.
23. Bast RC Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, et al. (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68: 1331-1337.
24. Yu D, Wolf JK, Scanlon M, Price JE, Hung MC, (1993) Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Cancer Res 53: 891-898.
25. Krasnykh VN, Mikheeva GV, Douglas JT, Curiel DT, (1996) Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol 70: 6839-6846.
26. Belousova N, Krendelchtchikova V, Curiel DT, Krasnykh V, (2002) Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein. J Virol 76: 8621-8631.
27. Krasnykh V, Dmitriev I, Mikheeva G, Miller CR, Belousova N, et al. (1998) Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J Virol 72: 1844-1852.
28. Chartier C, Degryse E, Gantzer M, Dieterle A, Pavirani A, et al. (1996) Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 70: 4805-4810.
29. Murakami M, Ugai H, Wang M, Belousova N, Dent P, et al. (2010) An adenoviral vector expressing human adenovirus 5 and 3 fiber proteins for targeting heterogeneous cell populations. Virology 407: 196-205.
30. Krasnykh V, Belousova N, Korokhov N, Mikheeva G, Curiel DT, (2001) Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin. J Virol 75: 4176-4183.
31. Maizel JV Jr, White DO, Scharff MD, (1968) The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 36: 115-125.
32. Glasgow JN, Kremer EJ, Hemminki A, Siegal GP, Douglas JT, et al. (2004) An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism. Virology 324: 103-116.
33. van Raaij MJ, Louis N, Chroboczek J, Cusack S, (1999) Structure of the human adenovirus serotype 2 fiber head domain at 1.5 A resolution. Virology 262: 333-343.
34. van Raaij MJ, Mitraki A, Lavigne G, Cusack S, (1999) A triple beta-spiral in the adenovirus fibre shaft reveals a new structural motif for a fibrous protein. Nature 401: 935-938.
35. Renaut L, Colin M, Leite JP, Benko M, D'Halluin JC, (2004) Abolition of hCAR-dependent cell tropism using fiber knobs of Atadenovirus serotypes. Virology 321: 189-204.
36. Murakami M, Ugai H, Belousova N, Pereboev A, Dent P, et al. (2009) Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells. The Prostate pp. n/a-n/a.
37. Ugai H, Borovjagin AV, Le LP, Wang M, Curiel DT, (2007) Thermostability/infectivity defect caused by deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in the core protein X precursor. J Mol Biol 366: 1142-1160.
38. Wesseling JG, Yamamoto M, Adachi Y, Bosma PJ, van Wijland M, et al. (2001) Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinoma. Cancer Gene Ther 8: 990-996.
39. Nakayama M, Both GW, Banizs B, Tsuruta Y, Yamamoto S, et al. (2006) An adenovirus serotype 5 vector with fibers derived from ovine atadenovirus demonstrates CAR-independent tropism and unique biodistribution in mice. Virology 350: 103-115.
40. Deutscher SL, Hirschberg CB, (1986) Mechanism of galactosylation in the Golgi apparatus. A Chinese hamster ovary cell mutant deficient in translocation of UDP-galactose across Golgi vesicle membranes. J Biol Chem 261: 96-100.
41. Stanley P, (1985) Membrane mutants of animal cells: rapid identification of those with a primary defect in glycosylation. Mol Cell Biol 5: 923-929.
42. Oelmann S, Stanley P, Gerardy-Schahn R, (2001) Point mutations identified in Lec8 Chinese hamster ovary glycosylation mutants that inactivate both the UDP-galactose and CMP-sialic acid transporters. J Biol Chem 276: 26291-26300.
43. Li H, d'Anjou M, (2009) Pharmacological significance of glycosylation in therapeutic proteins. Curr Opin Biotechnol 20: 678-684.
44. Schwarz F, Aebi M, (2011) Mechanisms and principles of N-linked protein glycosylation. Curr Opin Struct Biol 21: 576-582.
45. Dwek RA, (1996) Glycobiology: Toward Understanding the Function of Sugars. Chem Rev 96: 683-720.
46. Elbein AD, Solf R, Dorling PR, Vosbeck K, (1981) Swainsonine: an inhibitor of glycoprotein processing. Proc Natl Acad Sci U S A 78: 7393-7397.
47. Kuan SF, Byrd JC, Basbaum C, Kim YS, (1989) Inhibition of mucin glycosylation by aryl-N-acetyl-alpha-galactosaminides in human colon cancer cells. J Biol Chem 264: 19271-19277.
48. Nicklin SA, Wu E, Nemerow GR, Baker AH, (2005) The influence of adenovirus fiber structure and function on vector development for gene therapy. Mol Ther 12: 384-393.
49. Yin BW, Lloyd KO, (2001) Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J Biol Chem 276: 27371-27375.
50. Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, et al. (2007) American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 25: 5287-5312.
51. Cooper DN, (2002) Galectinomics: finding themes in complexity. Biochim Biophys Acta 1572: 209-231.
52. Perillo NL, Pace KE, Seilhamer JJ, Baum LG, (1995) Apoptosis of T cells mediated by galectin-1. Nature 378: 736-739.
53. Scott K, Weinberg C, (2004) Galectin-1: a bifunctional regulator of cellular proliferation. Glycoconj J 19: 467-477.
54. Liu FT, Yang RY, Hsu DK, (2012) Galectins in acute and chronic inflammation. Ann N Y Acad Sci 1253: 80-91.
55. Thijssen VL, Poirier F, Baum LG, Griffioen AW, (2007) Galectins in the tumor endothelium: opportunities for combined cancer therapy. Blood 110: 2819-2827.
56. Barrow H, Rhodes JM, Yu LG, (2011) The role of galectins in colorectal cancer progression. Int J Cancer 129: 1-8.
57. Liu FT, Rabinovich GA, (2005) Galectins as modulators of tumour progression. Nat Rev Cancer 5: 29-41.
58. Hirabayashi J, Kasai K, (1993) The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology 3: 297-304.
59. Nagae M, Nishi N, Murata T, Usui T, Nakamura T, et al. (2009) Structural analysis of the recognition mechanism of poly-N-acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domain. Glycobiology 19: 112-117.
60. Noureddini SC, Krendelshchikov A, Simonenko V, Hedley SJ, Douglas JT, et al. (2006) Generation and selection of targeted adenoviruses embodying optimized vector properties. Virus Res 116: 185-195.
61. Paul CP, Everts M, Glasgow JN, Dent P, Fisher PB, et al. (2008) Characterization of infectivity of knob-modified adenoviral vectors in glioma. Cancer Biol Ther 7: 786-793.
62. Do KY, Cummings RD, (1993) 2,6-branched mannose and the regulation of poly-N-acetyllactosamine biosynthesis in N-linked oligosaccharides of Chinese hamster ovary cells. J Biol Chem 268: 22028-22035.
63. Burmeister WP, Guilligay D, Cusack S, Wadell G, Arnberg N, (2004) Crystal structure of species D adenovirus fiber knobs and their sialic acid binding sites. J Virol 78: 7727-7736.
64. Connelly S, (1999) Adenoviral vectors for liver-directed gene therapy. Curr Opin Mol Ther 1: 565-572.
65. Alemany R, Curiel DT, (2001) CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther 8: 1347-1353.
66. Huard J, Lochmuller H, Acsadi G, Jani A, Massie B, et al. (1995) The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 2: 107-115.
67. Alba R, Bradshaw AC, Parker AL, Bhella D, Waddington SN, et al. (2009) Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood 114: 965-971.
68. Kalyuzhniy O, Di Paolo NC, Silvestry M, Hofherr SE, Barry MA, et al. (2008) Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci U S A 105: 5483-5488.
69. Shayakhmetov DM, Gaggar A, Ni S, Li ZY, Lieber A, (2005) Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J Virol 79: 7478-7491.
70. Smith TA, Idamakanti N, Rollence ML, Marshall-Neff J, Kim J, et al. (2003) Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice. Hum Gene Ther 14: 777-787.
71. Haviv YS, Blackwell JL, Kanerva A, Nagi P, Krasnykh V, et al. (2002) Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors. Cancer Res 62: 4273-4281.
72. Moullier P, Friedlander G, Calise D, Ronco P, Perricaudet M, et al. (1994) Adenoviral-mediated gene transfer to renal tubular cells in vivo. Kidney Int 45: 1220-1225.
73. Fujishiro J, Takeda S, Takeno Y, Takeuchi K, Ogata Y, et al. (2005) Gene transfer to the rat kidney in vivo and ex vivo using an adenovirus vector: factors influencing transgene expression. Nephrol Dial Transplant 20: 1385-1391.
74. Takeda S, Takahashi M, Mizukami H, Kobayashi E, Takeuchi K, et al. (2004) Successful gene transfer using adeno-associated virus vectors into the kidney: comparison among adeno-associated virus serotype 1-5 vectors in vitro and in vivo. Nephron Exp Nephrol 96: e119-126.
75. Heikkila P, Parpala T, Lukkarinen O, Weber M, Tryggvason K, (1996) Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system- first steps towards gene therapy of Alport syndrome. Gene Ther 3: 21-27.
76. Ortiz PA, Hong NJ, Plato CF, Varela M, Garvin JL, (2003) An in vivo method for adenovirus-mediated transduction of thick ascending limbs. Kidney Int 63: 1141-1149.